Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 5
1990 2
1991 7
1992 10
1993 16
1994 27
1995 32
1996 40
1997 33
1998 29
1999 29
2000 27
2001 21
2002 25
2003 22
2004 25
2005 25
2006 22
2007 13
2008 16
2009 20
2010 20
2011 19
2012 17
2013 18
2014 17
2015 21
2016 19
2017 12
2018 18
2019 21
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

608 results
Results by year
Filters applied: . Clear all
Page 1
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L, Kelly GL. Fitzsimmons L, et al. Viruses. 2017 Nov 13;9(11):339. doi: 10.3390/v9110339. Viruses. 2017. PMID: 29137176 Free PMC article. Review.
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma (BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are as yet, no EBV-targeted therapies available. ...Since manipulation of the cell …
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma (BL), and is now known to be a contributo …
An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC. Romero-Masters JC, et al. PLoS Pathog. 2018 Aug 20;14(8):e1007221. doi: 10.1371/journal.ppat.1007221. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30125329 Free PMC article.
EBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infected cells, is required for EBV transformation of B cells in vitro. ...The anti-apoptotic proteins, BCL2 and IRF4, were expressed
EBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infecte
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.
Ok CY, Li L, Young KH. Ok CY, et al. Exp Mol Med. 2015 Jan 23;47(1):e132. doi: 10.1038/emm.2014.82. Exp Mol Med. 2015. PMID: 25613729 Free PMC article. Review.
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting >90% of the adult population. EBV targets B-lymphocytes and achieves latent infection in a circular episomal form. ...Here we review our current understanding of EBV-induced lymphomagen …
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting >90% of the adult population. EBV targets B-lymphocy …
Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q, Han T, Sheng X, Zhang N, Wang P. Wu Q, et al. Biomed Pharmacother. 2018 Dec;108:741-751. doi: 10.1016/j.biopha.2018.08.146. Epub 2018 Sep 21. Biomed Pharmacother. 2018. PMID: 30248542 Free article.
OBJECTIVE: This study aims to explore the role of Epstein-Barr virus (EBV) miR-BART4 in occurrence and progression of nasopharyngeal carcinoma (NPC) and its effect on radiosensitivity. ...RESULTS: Positive rate of EBV in NPC tissues (93.5%) was remarkably higher tha …
OBJECTIVE: This study aims to explore the role of Epstein-Barr virus (EBV) miR-BART4 in occurrence and progression of nasopharyngeal …
Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis.
Sugita Y, Muta H, Ohshima K, Morioka M, Tsukamoto Y, Takahashi H, Kakita A. Sugita Y, et al. Neuropathology. 2016 Aug;36(4):313-24. doi: 10.1111/neup.12276. Epub 2015 Nov 26. Neuropathology. 2016. PMID: 26607855 Review.
The pathological characteristics of primary CNS EBV-positive diffuse large B-cell lymphoma of the elderly have similarities with those of the latency phenotype III, EBV lymphoproliferative disorders that arise in the setting of immunodeficiency. These age-related ly …
The pathological characteristics of primary CNS EBV-positive diffuse large B-cell lymphoma of the elderly have similarities with thos …
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes.
Zhou Y, Xu Z, Lin W, Duan Y, Lu C, Liu W, Su W, Yan Y, Liu H, Liu L, Zhong M, Zhou J, Zhu H. Zhou Y, et al. Front Oncol. 2019 Jul 25;9:683. doi: 10.3389/fonc.2019.00683. eCollection 2019. Front Oncol. 2019. PMID: 31403034 Free PMC article.
We include 236 DLBCL patients for EBV-encoded mRNA (EBER) in situ hybridization detection and analyzed 9 EBV+ and 6 EBV negative cases by next-generation sequencing (NGS). ...The most frequently mutated genes in EBV+ DLBCL were MYC (3/9; 33.3%), RHOA ( …
We include 236 DLBCL patients for EBV-encoded mRNA (EBER) in situ hybridization detection and analyzed 9 EBV+ and 6 EBV
Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
Szumera-Ciećkiewicz A, Rymkiewicz G, Grygalewicz B, Jesionek-Kupnicka D, Gruchała A, Ziarkiewicz-Wróblewska B, Gałązka K, Reszeć J, Borg K, Prochorec-Sobieszek M. Szumera-Ciećkiewicz A, et al. Pol J Pathol. 2018;69(1):1-19. doi: 10.5114/pjp.2018.75332. Pol J Pathol. 2018. PMID: 29895122 Free article. Review.
EBV-positive diffuse large B-cell lymphoma, not otherwise specified. Still the histopathological diagnostics is based on morphology and immunoprofile, but to define the HGBLs evaluation of MYC, BCL2, and BCL6 gene statuses is required. ...
EBV-positive diffuse large B-cell lymphoma, not otherwise specified. Still the histopathological diagnostics is based on morphology a
EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.
Courville EL, Yohe S, Chou D, Nardi V, Lazaryan A, Thakral B, Nelson AC, Ferry JA, Sohani AR. Courville EL, et al. Mod Pathol. 2016 Oct;29(10):1200-11. doi: 10.1038/modpathol.2016.130. Epub 2016 Jul 22. Mod Pathol. 2016. PMID: 27443517 Free article.
We retrospectively identified 32 cases of monomorphic post-transplant lymphoproliferative disorder from two institutions and evaluated EBV in situ hybridization; TP53 mutation status; p53, CD30, myc, and BCL2 expression by immunohistochemistry; proliferation index b …
We retrospectively identified 32 cases of monomorphic post-transplant lymphoproliferative disorder from two institutions and evaluated EB
Epstein-Barr Virus BALF0 and BALF1 Modulate Autophagy.
Shao Z, Borde C, Quignon F, Escargueil A, Maréchal V. Shao Z, et al. Viruses. 2019 Nov 27;11(12):1099. doi: 10.3390/v11121099. Viruses. 2019. PMID: 31783609 Free PMC article.
Previous works showed that the Epstein-Barr virus (EBV), a human transforming gammaherpesvirus, hijacked autophagy during the lytic phase of its cycle, possibly to favor the formation of viral particles. However, the viral proteins that are responsible for an EBV
Previous works showed that the Epstein-Barr virus (EBV), a human transforming gammaherpesvirus, hijacked autophagy during the …
Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
Song W, Liu MG, Zhang JB, Zhang JJ, Sun MM, Yu QK. Song W, et al. Eur Rev Med Pharmacol Sci. 2016;20(6):1093-7. Eur Rev Med Pharmacol Sci. 2016. PMID: 27049262 Free article.
Besides, the correlation of EBV with p53, Bcl-2, Rb and c-Myc were investigated in NHLs of observation group. RESULTS: In the observation group, the expression rates of EBV(+), p53(+), Bcl-2(+), Rb(-), and c-Myc(+) were significantly higher than those, respectively, …
Besides, the correlation of EBV with p53, Bcl-2, Rb and c-Myc were investigated in NHLs of observation group. RESULTS: In the observa …
608 results
Jump to page
Feedback